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Abstract
Methylenetetrahydrofolate reductase (MTHFR) generates methyltetrahydrofolate for methylation reactions. Severe MTHFR
deficiency results in homocystinuria and neurologic impairment. Mild MTHFR deficiency (677C>T polymorphism) increases
risk for complex traits, including neuropsychiatric disorders. Although low dietary folate impacts brain development, recent
concerns have focused on high folate intake following food fortification and increased vitamin use. Our goal was to
determine whether high dietary folate during pregnancy affects brain development in murine offspring. Female mice were
placed on control diet (CD) or folic acid-supplemented diet (FASD) throughout mating, pregnancy and lactation. Three-week-
old male pups were evaluated for motor and cognitive function. Tissues from E17.5 embryos, pups and dams were collected
for choline/methyl metabolite measurements, immunoblotting or gene expression of relevant enzymes. Brains were exam-
ined for morphology of hippocampus and cortex. Pups of FASD mothers displayed short-term memory impairment, de-
creased hippocampal size and decreased thickness of the dentate gyrus. MTHFR protein levels were reduced in FASD pup
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livers, with lower concentrations of phosphocholine and glycerophosphocholine in liver and hippocampus, respectively.
FASD pup brains showed evidence of altered acetylcholine availability and Dnmt3a mRNA was reduced in cortex and hippo-
campus. E17.5 embryos and placentas from FASD dams were smaller. MTHFR protein and mRNA were reduced in embryonic
liver, with lower concentrations of choline, betaine and phosphocholine. Embryonic brain displayed altered development of
cortical layers. In summary, high folate intake during pregnancy leads to pseudo-MTHFR deficiency, disturbed choline/methyl
metabolism, embryonic growth delay and memory impairment in offspring. These findings highlight the unintended nega-
tive consequences of supplemental folic acid.
Introduction
Folate derivatives are critical for brain development and neuro-
transmitter synthesis because they provide one-carbon units
for nucleotide synthesis and methylation reactions (1). One of
the most studied enzymes in the folate metabolic pathway is
methylenetetrahydrofolate reductase (MTHFR, EC 1.5.1.20), a
ubiquitous enzyme which generates 5-methyltetrahydrofolate
(5-methylTHF) for remethylation of homocysteine to methio-
nine (2). Methionine is the precursor of S-adenosylmethionine
(SAM), the primary methyl donor in most mammalian methyla-
tion reactions. An alternate folate-independent pathway for
methionine synthesis is present primarily in liver and kidney; it
uses the choline metabolite betaine as a methyl donor.
Disturbances in folate metabolism can be genetic and/or dietary
and often result in compensatory disturbances in choline me-
tabolism. Choline is required to synthesize the neurotransmit-
ter acetylcholine and critical phospholipids for membrane
integrity (3,4).
Relatively rare severe deficiencies in MTHFR (usually<20%
of enzyme activity) are a cause of homocystinuria, an inborn er-
ror of metabolism characterized by a variety of neurologic
symptoms including developmental delays, motor disturbances
and brain atrophy (5). A mild deficiency in MTHFR, due to the
677C>T (A222V) polymorphism, is present in the homozygous
state in 10–15% of many Caucasian populations and encodes a
thermolabile enzyme with 30% residual activity (2). This SNP
has been reported to increase risk for neural tube defects, preg-
nancy complications and neuropsychiatric diseases such as
schizophrenia and autism (3,6–8). To study these complex traits,
we developed mouse models that mimic these MTHFR deficien-
cies (9). Mthfr-/- mice, a model for homocystinuria, have short-
term memory impairment, altered hippocampal morphology
and disturbed acetylcholine metabolism (10). Heterozygous
MTHFR deficiency in dams (Mthfrþ/- mice) resulted in memory
impairment in their pups (11).
Folate cannot be synthesized by humans and must be ac-
quired from the diet (12). Low maternal folate intake during
pregnancy is a risk factor for neural tube defects and other birth
defects, as well as other pregnancy complications including in-
trauterine growth restriction (3). Low maternal folate intake has
also been associated with disturbances in offspring brain func-
tion, since the developing brain is sensitive to nutrient deple-
tion during gestation and early development. In both humans
and rodents, folate deficiency during pregnancy has been asso-
ciated with cognitive impairment, increased anxiety and de-
pression (13,14). In mice, maternal folate-deficient or choline-
deficient diets lead to increased apoptosis in fetal brain, particu-
larly the hippocampus (11,15).
In a public health effort to reduce the incidence of neural
tube defects, grains have been fortified with folic acid in over 50
countries. The recommended daily intake for adults is 0.4 mg
with a recommended tolerable upper intake level of 1 mg (16).
However, there are groups in the population that are consuming
4–5 mg/day, primarily due to the increased use of vitamin sup-
plements (17,18). Concerns have emerged about the possible
consequences of high folic acid intake; these concerns include
increased growth of sub-clinical tumors, the possibility of mask-
ing B12 deficiency and impaired immune function (16,19). We
have been investigating potential adverse outcomes of high fo-
lic acid intake in mice. We found that adult male mice fed a folic
acid supplemented diet (FASD, 10 the recommended amount
for rodents) for 6 months developed a pseudo-MTHFR defi-
ciency, with hepatic injury (20).
The use of vitamin supplements is particularly important for
women of childbearing age, although high-dose supplementa-
tion with folic acid raises questions about possible negative ef-
fects on their offspring, particularly on brain development (21).
Therefore, in this study we aimed to determine whether high
maternal folic acid intake in mice affected brain function or me-
tabolism in their pups and embryos. Towards this end, we fed
wild-type female mice a control diet (CD) or FASD for 5 weeks
prior to mating, and maintained the diets throughout preg-
nancy and lactation, to assess brain development in offspring.
We found that offspring of mothers fed FASD had intra-uterine
growth delay, short-term memory impairment and altered
brain development. Maternal and offspring pseudo-MTHFR defi-
ciency with disturbances in choline/methyl metabolism are
likely to have contributed to these outcomes.
Results
Three-week-old pups born to FASDmothers had
short-termmemory impairment and reduced
hippocampal area
There were no differences in body weights of pups between the
two dietary groups (Supplementary Material, Fig. S1A).
Behavioral testing was performed on 3-week-old male pups to
assess brain function. In the ladder beam test for measurement
of gait, there were no differences in percent error or movement
score (Supplementary Material, Fig. S1B). In the open field test,
which evaluates anxiety, there were no differences in the activ-
ity pattern or number of field entries (Supplementary Material,
Fig. 1C). To assess memory, the novel object recognition test
(NOR) and the Y-maze test were performed. No differences were
observed in the Y-maze test suggesting there were no differ-
ences in spatial memory (Supplementary Material, Fig. 1D).
However, mice from FASD mothers had a negative discrimina-
tion index in the NOR, i.e. these pups spent significantly less
time with the novel object than with the familiar object (Fig. 1A;
P< 0.005, unpaired t-test). These findings suggest that pups
from FASD mothers have short-term memory impairment, a
phenotype that was also observed in Mthfr-/- mice (10). Since we
had previously observed that Mthfr-/- mice had reduced hippo-
campal volume, we measured the area of the hippocampus and
the thickness of the dentate gyrus (DG) in sagittal brain sections
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of pups; both were reduced due to FASD (P< 0.005 and P< 0.05,
respectively, unpaired t-test) (Fig. 1B–G).
Maternal FASD during pregnancy and lactation led to
pseudo-MTHFR deficiency in offspring liver
We previously reported that FASD leads to pseudo-MTHFR defi-
ciency in adult male liver (20). We therefore measured MTHFR
protein levels in liver of 3-week-old offspring. We found a 3-fold
decrease in total MTHFR protein (Fig. 2A and C; P< 0.05, un-
paired t-test) and a 4-fold increase in the ratio of the phosphory-
lated to non-phosphorylated isoform of MTHFR (Fig. 2B and C;
P< 0.005, unpaired t-test). Decreased phosphorylation has been
reported to increase MTHFR activity by 1.2 fold in vitro; the effect
of phosphorylation in vivo has not been examined (22). No
changes were detected at the mRNA level (data not shown).
These data are consistent with our previous report and suggest
that offspring born to FASD mothers have pseudo-MTHFR
deficiency.
We also measured MTHFR levels in the cortex and hippo-
campus, two brain regions that impact performance in the NOR
test, but no differences in total immunoreactive MTHFR levels
were detected (data not shown). Consistent with this observa-
tion, there were no differences in the percentages of THF and its
one-carbon substituted derivatives in the hippocampus
between the two dietary groups (Supplementary Material,
Table S1).
Choline metabolism was disturbed in liver and brain
of FASD pups
In several other studies, we have shown that disturbances in fo-
late metabolism are often accompanied by disturbances in cho-
line metabolism, because these two pathways intersect in the
Figure 1. Pups born to mothers fed high folate diet had short-term memory impairment and reduced hippocampal area. (A) Three-week-old male mice were tested us-
ing the NOR. The discrimination index is the ratio of time spent with the novel object versus time with the familiar object; a negative discrimination index indicates
short-term memory impairment. Data from two independent experiments are shown (n¼15–20/group). (B) The average area of the hippocampus and (C) the average
thickness of the dentate gyrus (DG) were reduced in FASD pups (n¼5/group). Representative images of hippocampus and DG from CD pup (D and F, respectively)
and FASD pup (E and G, respectively) are shown. Arrows in the DG indicate where the thickness measurements were performed. Values are means 6 SEM; *P < 0.05,
***P < 0.005.
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provision of methyl donors for methionine/SAM synthesis
(10,20,23). We therefore measured SAM, SAH, choline and
related metabolites in offspring liver, the primary organ of
one-carbon metabolism. We did not observe differences in
SAM, SAH, choline, betaine, glycerophosphocholine (GPC),
phosphatidylcholine, sphingomyelin or lysophosphatidylcho-
line (Supplementary Material, Table S2). However, there was a
significant 30% decrease in phosphocholine (PCho), the primary
storage form of choline (Fig. 3A; P< 0.05, unpaired t-test).
We also measured choline metabolites in hippocampus
(Supplementary Material, Table S2) and observed a trend for de-
creased levels of GPC in offspring (Fig. 3B; P¼ 0.06, unpaired t-
test), suggesting an increased conversion of GPC to choline to
replenish choline pools.
Choline is a precursor of acetylcholine (Ach), a neurotrans-
mitter that plays a role in memory (4). mRNA levels of acetyl-
cholinesterase (AchE), which cleaves acetylcholine at the
synaptic cleft, were measured in cortex and hippocampus. AchE
mRNA was significantly reduced in the FASD group in cortex
(Fig. 3C; P< 0.05, unpaired t-test with Welsh’s correction).
Cortical mRNA levels of the nicotinic receptor of acetylcholine,
Chrna7, were decreased in the FASD group but did not reach sta-
tistical significance (data not shown). However, we observed a
significant correlation between AchE and Chrna7 levels in cortex
(Fig. 3D; r¼ 0.894, P< 0.05). AchE and Chrna7 mRNA levels did not
change in hippocampus (data not shown).
We also measured immunoreactive protein levels of choline
acetyltransferase (ChAT), the enzyme that synthesizes Ach
from choline; there were no differences in cortical or hippocam-
pal extracts (data not shown). However, when we stained for
cholinergic neurons in the Substantia Innominata (SI), which
project to the cortex, we found a trend for reduced ChAT stain-
ing in FASD pups (Fig. 3E; P¼ 0.07, unpaired t-test). There was
no significant difference in the number of cholinergic neurons
(Fig. 3F).
FASD pups had reduced expression of Dnmt3a
Maternal high folic acid intake can result in methylation
changes in the brain of offspring (24), and DNA methyltransfer-
ases have been shown to be involved in memory (25). We there-
fore measured mRNA levels of DNA methyltransferases in
offspring cortex and hippocampus. We observed a significant
decrease in Dnmt3a mRNA in cortex and hippocampus (Fig. 4A
and B, respectively; P< 0.05, unpaired t-test). We did not observe
changes in Dnmt1 (Fig. 4C) or Dnmt3b (Fig. 4D) in cortex, suggest-
ing that this effect is specific to the de novo methyltransferase
Dnmt3a.
FASD resulted in pseudo-MTHFR deficiency and altered
folate and choline metabolism in lactating mothers
There were no differences in maternal body weights between
groups (CD: 24.86 1.8; FASD: 26.56 1.7). As seen in offspring, there
was a decrease in total MTHFR protein in maternal liver (Fig. 5A;
P< 0.05, unpaired t-test) and an increased ratio of phosphorylated
to non-phosphorylated MTHFR (Fig. 5B; P< 0.005, unpaired t-test).
We measured mRNA expression of other important enzymes
in one-carbon metabolism. Methionine synthase (Mtr) is the en-
zyme responsible for remethylating homocysteine to methio-
nine using 5-methylTHF generated by MTHFR. In maternal liver,
Mtr mRNA levels significantly decreased due to diet (Fig. 5C;
P< 0.005, unpaired t-test). mRNA for methionine synthase re-
ductase (Mtrr), the enzyme required to activate Mtr, was in-
creased (Fig. 4D; P< 0.005, unpaired t-test), possibly as a
compensatory mechanism for reduced Mtr.
Phosphatidylethanolamine methyltransferase (Pemt) converts
phosphatidylethanolamine into phosphatidylcholine, the precur-
sor of GPC (26). We observed increased Pemt mRNA levels due to
diet (Fig. 5E; P< 0.005, unpaired t-test). Choline metabolites were
measured in maternal liver and plasma. No changes were ob-
served in liver or plasma for choline, betaine, phosphatidylcholine,
PCho, sphingomyelin or lysophosphatidylcholine (Supplementary
Material, Table S3). However, there was a trend towards reduced
GPC concentrations in maternal plasma (Fig. 5F; P¼ 0.06, unpaired
t-test). The increase in Pemt may be a compensatory mechanism to
increase circulating GPC for the generation of choline.
Embryos and placentas of FASDmothers were smaller
at E17.5
To understand the effects of FASD during early brain develop-
ment, we collected maternal and embryonic tissues at E17.5
from mothers fed CD and FASD. There were no differences in
maternal body weights (CD: 29.961.7; FASD: 30.162.1) or litter
sizes (CD: 661.5; FASD: 8.360.3) between groups. However, av-
erage fetal body weight per litter was significantly reduced in
the FASD group (Fig. 6A; P< 0.05, unpaired t-test) and there was
a trend towards reduced placental weight per litter (Fig. 6B;
P¼ 0.08, unpaired t-test), suggesting that a high folate diet dur-
ing pregnancy leads to growth delay in embryos.
FASD embryos showed reduced expression of
one-carbon enzymes in liver, reduced hepatic
choline metabolites and altered brain development
At E17.5 the embryo is metabolically active and relies less on
maternal metabolism (27). In the FASD group, we observed a
Figure 2. Pups born to mothers fed high folate diet had pseudo-MTHFR deficiency in liver. (A) Total immunoreactive MTHFR protein was reduced in livers of FASD
pups. (B) The ratio of the phosphorylated isoform (p-MTHFR, less active) to the non-phosphorylated isoform (MTHFR) was increased in FASD pups. (C) Representative
Western blot of MTHFR in offspring liver. Values are means6 SEM from 5 mice/group; *P<0.05, ***P<0.005.
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decrease in total MTHFR protein levels in embryonic liver
(Fig. 7A; P< 0.05, unpaired t-test), with no differences in isoform
ratio (data not shown). These results indicate that the pseudo-
MTHFR deficiency is present prenatally. Of additional interest
was our finding of decreased Mthfr mRNA levels (Fig. 7B;
P< 0.05, unpaired t-test). Changes in Mthfr mRNA were not ob-
served due to FASD in the 3-week-old pups or in our earlier
study of adult mice (20), suggesting a different regulatory mech-
anism for MTHFR at the embryonic stage.
We also found a trend towards reduced betaine homocyste-
ine methyltransferase (Bhmt) mRNA in FASD embryonic liver
(Fig. 7C; P¼ 0.08, unpaired t-test). This enzyme utilizes the cho-
line derivative betaine for methionine and SAM synthesis.
Key enzymes in the synthesis and utilization of SAM were also
decreased by FASD. Expression of methionine adenosyltransfer-
ase 1A (Mat1a) (Fig. 7D), the enzyme that synthesizes SAM from
methionine, and of Pemt (Fig. 7E), a major consumer of SAM for
phosphatidylcholine synthesis, were reduced (P< 0.005, un-
paired t-test).
Several of choline/methyl metabolites measured in embry-
onic liver were not affected by diet (GPC, phosphatidylcholine,
sphingomyelin, lysophosphatidylcholine, SAM and SAH)
(Supplementary Material, Table S4). However, in FASD liver,
betaine was significantly decreased (Fig. 8A; P< 0.05,
unpaired t-test), there was a trend towards decreased choline
(Fig. 8B; P¼ 0.06, unpaired t-test) and PCho significantly
Figure 3. Pups born to mothers fed high folate diet had disturbances in choline and acetylcholine metabolism. (A) The concentration of phosphocholine (PCho), the
storage form of choline, was significantly decreased in liver (n¼ 6/group). (B) In hippocampus, there was a trend towards reduced glycerophosphocholine (GPC) in FASD
pups (n¼7/group, #P¼0.06). (C) mRNA expression of acetylcholinesterase (AchE) was reduced in cortex of FASD pups (n¼7/group). (D) mRNA levels of the nicotinic re-
ceptor of acetylcholine, Chrna7 and AchE in cortex were significantly positively correlated (n¼7/group; r¼0.894, P<0.05). ChAT staining to measure (E) staining inten-
sity and (F) numbers of cholinergic neurons in the Substantia Innominata (SI). There was a trend towards reduced intensity of ChAT staining in the SI of FASD pups
(n¼5/group, #P¼0.07) but no significant difference in number of cholinergic neurons. Values are means6 SEM; *P < 0.05.
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decreased (Fig. 8C; P< 0.005, unpaired t-test). These observa-
tions suggest that the choline/betaine-dependent remethyla-
tion pathway is being extensively utilized when folate-
dependent remethylation is blocked, as we have previously ob-
served (10,23,28).
To examine cortical and hippocampal development in E17.5
embryos, we examined H&E stained coronal brain sections. The
cortical layers appeared to be more defined in FASD embryos
(Fig. 9B and D) compared with CD embryos (Fig. 9A and C), and
the cortical cells appeared to be more developed due to their
elongated shape. These observations suggest different rates of
cortical development due to diet. We also observed increased
thickness of the SVZ in FASD embryos (Supplementary Material,
Figure S3). Additional experimentation is required to under-
stand the nature of these developmental differences.
Pregnant mothers at E17.5 showed relatively minor
changes in one-carbon metabolism
Total hepatic MTHFR protein was not changed by diet in the
pregnant females, although there was an increase in the ratio of
phosphorylated to non-phosphorylated MTHFR in the FASD
group (P< 0.05, unpaired t-test, data not shown). Similar to our
results in lactating mothers, there was a decrease in Mtr mRNA
(P< 0.05, unpaired t-test) due to FASD in livers of pregnant fe-
males (Supplementary Material, Fig. S2A).
The placenta, which has significantly higher levels of
MTHFR compared with embryonic or maternal liver, did not
show differences in MTHFR protein levels due to diet
(Supplementary Material, Fig. S2B and C). Consequently, we did
not observe any changes in choline metabolites or SAH in pla-
centa or maternal liver. There was a trend for increased SAM in
the placenta (P¼ 0.07, unpaired t-test); however this small dif-
ference may not have biological relevance (Supplementary
Material, Table S5). These findings suggest that embryonic fo-
late metabolism may be independent of maternal metabolism
at this stage and that FASD has more dramatic consequences
on embryos than on dams.
Discussion
High folate intake is commonly observed in several population
sub-groups, including pregnant women, raising concerns about
the possible negative consequences on the child’s development
(29). We investigated the effect of high folate consumption dur-
ing pregnancy and lactation on offspring brain function. Three-
week-old pups born to FASD mothers had short-term memory
impairment. Memory impairment was also observed in our ear-
lier report of Mthfr-/- mice (10). This similarity is particularly in-
teresting because we found that the pups of FASD mothers had
pseudo-MTHFR deficiency. Total MTHFR protein levels were re-
duced and there was an increased ratio of the phosphorylated
(less active) to non-phosphorylated isoform. Our first finding of
pseudo-MTHFR deficiency with high folate intake was in the
liver of adult male mice maintained on FASD for 6 months (20).
The observations in this study of reduced MTHFR protein in liv-
ers of pups, embryos and lactating dams suggest that this phe-
nomenon is seen in various ages and sexes, at least for liver.
Figure 4. Pups of FASD mothers had reduced expression of Dnmt3a mRNA in cortex and hippocampus. There was a significant decrease of Dnmt3a mRNA due to FASD
in (A) cortex (n¼7/group) and (B) hippocampus of FASD pups (n¼5/group). (C) Dnmt1 and (D) Dnmt3b mRNA were not changed by diet in cortex. Values are
means6SEM; *P<0.05.
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Figure 5. High folic acid intake altered folate metabolism in liver of lactating mothers and led to changes in choline metabolism. (A) Total MTHFR protein was reduced
in FASD mothers (n¼5/group). (B) The ratio of the phosphorylated MTHFR isoform (less active) to the non-phosphorylated isoform was increased in the FASD group
(n¼5/group). mRNA expression of (C) methionine synthase (Mtr) was reduced, (D) methionine synthase reductase (Mtrr) was increased and (E) Pemt was increased due
to FASD (n¼7/group). (F) There was a trend towards lower GPC due to diet in maternal plasma, (n¼7/group, #P¼0.06). Values are means6SEM; *P<0.05, ***P<0.005.
Figure 6. Embryos and placentas from FASD mothers were smaller at E17.5. Weights of embryos and placentas were measured at sacrifice. (A) FASD led to lower mean
body weights/litter of embryos. (B) There was a trend toward lower placental weights/litter (#P¼0.08). Values are means6SEM of 6 l/group; *P<0.05.
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Pregnant dams exhibited increased MTHFR phosphorylation,
which would be expected to reduce MTHFR activity (22), but to-
tal MTHFR protein was not altered. It is possible that the reduc-
tion in total protein requires a longer exposure to the folate-
supplemented diet, since we observed both inhibitory mecha-
nisms in lactating mothers. We did not observe changes in
MTHFR protein in cortex, hippocampus or placenta due to high
folate. Altered expression of liver MTHFR is known to lead to he-
patic choline disturbances. Choline is an alternate methyl donor
for SAM synthesis, through its metabolite betaine; this alternate
pathway is usually upregulated when folate-dependent SAM
synthesis is inhibited (20,28). This upregulation may decrease
circulating critical choline metabolites and can ultimately affect
brain choline utilization for Ach production.
Phosphocholine, the primary storage form of choline, was
reduced in liver of 3-week old pups. There was a trend for re-
duced GPC in pup hippocampus; this decrease could be due to
the increased conversion of GPC to choline in order to maintain
choline pools (23). Importantly, choline is the precursor of Ach.
We found a trend toward decreased ChAT staining in choliner-
gic neurons in the SI, and a decrease in mRNA levels of AchE in
cortex. Chrna7 mRNA levels also tended to decrease in FASD
pup cortex; the difference was not significant although AchE
and Chrna7 mRNAs were highly positively correlated. Chrna7
mRNA levels were found to be decreased in post-mortem brains
of schizophrenia patients which was likely due to increased ex-
pression of the transcription factor Activating Protein-2a (AP-
2a), a negative regulator of AchE (30). Therefore, it is possible
that the observed correlation is due to the co-regulation of these
genes by AP-2a. These changes suggest that there is a distur-
bance in acetylcholine metabolism, which could be contributing
to memory impairment in offspring. The hippocampus and the
cortex are critical regions for memory and learning (31). The re-
duced area of the hippocampus in general and the reduced
thickness of the dentate gyrus in particular in FASD pups is con-
sistent with the impaired memory and with our earlier work in
which we also found decreased hippocampal volume and mem-
ory impairment in Mthfr-/- mice (10).
At E17.5, the hippocampus and upper layers of the cortex are
rapidly developing (32) and reduced choline availability may
have adverse consequences on embryonic brain development.
Maternal choline-deficient diets in mice resulted in decreased
Figure 7. Maternal FASD altered expression of one-carbon enzymes in liver of E17.5 embryos. (A) Total MTHFR protein and (B) Mthfr mRNA was reduced in liver of E17.5
FASD embryos. (C) There was a trend towards reduced Bhmt mRNA in embryonic liver (#P¼0.08). (D) Mat1a and (E) Pemt mRNA were both significantly decreased due to
diet in embryonic liver. Values are means6SEM of 7–8 embryos/group; *P<0.05, ***P<0.005.
Figure 8. Choline metabolites decreased in E17.5 embryonic liver of FASD mothers. (A) Betaine concentration was significantly decreased. (B) There was a trend towards
reduced choline (#P¼0.06) (C) Pcho concentration was significantly decreased. Values are means6SEM of 6 embryos/group; *P<0.05, ***P<0.005.
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proliferation and increased apoptosis in hippocampus (33), and
altered neurogenesis and cortical layering, particularly in later
born neurons (34). We examined proliferation in hippocampus
and cortex at E17.5 using Ki67 (data not shown) but did not ob-
serve any differences. More extensive marker analyses at vari-
ous time points would be useful to understand developmental
differences.
Reduced choline availability can also modulate the expres-
sion of DNA and histone methyltransferases (35,36). We ob-
served significant disturbances in choline metabolites in FASD
embryos, and decreased Dnmt3a mRNA in both cortex and hip-
pocampus of FASD pups. Dnmt3a plays an important role in
brain development and neuronal maturation (37). Mice with a
conditional knockout of Dnmt3a performed poorly on memory
tasks, particularly the NOR (25). Decreased Dnmt3a expression
would be expected to alter DNA methylation and consequently
expression of genes that may be essential for brain develop-
ment. Increased maternal folic acid intake has been shown to
alter methylation and expression of neurodevelopmental genes
in a sex-specific manner in newborn pups (24,38). The differ-
ences in rate of brain development in this study may be linked
to altered Dnmt3a expression.
The average weight of embryos per litter was reduced in the
FASD group. The observed phenotype is reminiscent of the in-
trauterine growth restriction observed in low folate conditions
(39,40). Therefore, high folate consumption may have similar
negative effects to those seen with low folate, particularly since
high folate inhibits MTHFR, a critical folate enzyme, and could
be inhibiting other folate-dependent enzymes or transporters.
Embryos from FASD mothers had pseudo-MTHFR deficiency
with significant disturbances in folate and choline metabolism.
The embryo is a system that is rapidly proliferating and devel-
oping with high nutrient demands. There were no dramatic
changes in metabolites of pregnant mice. These observations
suggest that at this stage of development, embryonic folate and
choline metabolism is working relatively independently of ma-
ternal metabolism.
In contrast to pregnant females, the lactating FASD mice had
more marked changes due to diet: reduced MTHFR protein,
significant disturbances in one-carbon metabolism and their
Pemt levels were increased in liver, possibly to maintain choline
levels. Maternal metabolism during lactation is critical for
maintaining nutrients that are transferred to pups through
milk. Nonetheless, we cannot exclude the possibility that the
differences between pregnant and lactating mothers are due to
the longer period of exposure to FASD and decreased MTHFR
protein in lactating dams, instead of a differential response dur-
ing pregnancy or lactation.
Our findings are in line with recent human studies that ex-
amined the effects of excess maternal folate intake on offspring
health. Mothers who consumed the highest amounts of folic
acid had children with reduced embryonic size (41). The mem-
ory impairment in newborn pups from FASD dams in this study
is consistent with findings in a Spanish study demonstrating
that the children whose mothers consumed over 5mg/day of fo-
lic acid periconceptionally had delayed psychomotor develop-
ment (21). In addition, there is a recent report that high
maternal plasma folate was associated with an increased risk of
autism spectrum disorder in offspring (42).
In summary, we have shown that high folic acid intake in
pregnant mice leads to intrauterine growth delay with altered
brain development and impaired memory in offspring. We sug-
gest that these outcomes may be due to pseudo-MTHFR defi-
ciency in both offspring and mothers, with consequent
disturbances in choline and methyl metabolism. This study
adds to the increasing evidence that over-consumption of folic
acid during pregnancy may have negative health consequences
and that determining a safe upper limit is critical.
Materials and Methods
Animal experimentation and diets
Animal experimentation was conducted according to the guide-
lines of the Canadian Council on Animal Care and approved by
the Animal Care Committee of the Research Institute of the
McGill University Health Center. Mice were housed in specific
pathogen free facilities with 12 h light/dark cycles with food and
Figure 9. Altered brain development in embryos of FASD mothers. Coronal sections of embryonic brain were stained with H & E. Representative images from embryos
in the CD (A and C) and FASD (B and D) groups are depicted. Images show the cortical layers, the intermediate zone (IZ) and subventricular zone (SVZ). Cortical layers
from FASD embryos appeared to be more organized and developed.
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water ad libitium. At weaning, wild-type C57BL/6 female mice
were placed on amino acid defined Control Diet (CD) (2 mg folic
acid/kg diet, recommended level for rodents (43) (TD.01369,
Harlan Laboratories, Inc., Madison, WI, USA) or Folic Acid
Supplemented Diet (FASD) which contained 10 times the
amount of folic acid (20 mg folic acid/kg diet, TD.09258, Harlan
Laboratories, Inc., Madison, WI, USA). Both diets contained
2.5 g/kg choline bitrate, 3.3 g/kg L-methionine and 1% succinyl-
sulfathiazole, an antibiotic that inhibits folate synthesis by in-
testinal flora. Five weeks after the start of the diets, females
were mated with wild-type C57BL/6 males. The morning of the
presence of a vaginal plug was considered as day 0.5 of gesta-
tion. For embryo collection, the mice were sacrificed at embry-
onic day (E) 17.5 of gestation, and maternal and embryonic
tissues were collected. In a second group, female mice were
maintained on the diets through pregnancy and lactation (until
sacrifice). Maternal tissues and tissues from 3-week-old male
pups were collected after completion of behavioral testing of
pups.
Behavioral testing
All behavioral tests were performed as described in Ref. (10).
Brief descriptions of the methods of individual tests are as
follows:
Open field test
Mice were placed in the middle of an open field box and allowed
to explore for 5 min. The bottom of the open field was divided
into 16 equal squares. Recorded videos were analyzed for activ-
ity (total number of squares crossed), number of entries into in-
ner squares and outer squares and % time spent in each.
Ladder beam test
The apparatus consisted of two Plexiglass walls and metal bars
between walls arranged in an irregular pattern, and was placed
on top of a mouse housing cage. Recordings were obtained from
each mouse and analyzed frame-by-frame. The error score was
the combination of total number of errors and the number of
steps for each limb.
Novel object recognition test
Pups were allowed to habituate to the room for 30 min and then
to the apparatus (open field) for 10 min. Animals explored two
identical copies of object 1 placed at opposite corners in an
open field for 8 min (trial phase), then returned to their cages for
one hour. Short-term memory was assessed by allowing ani-
mals to explore a familiar object (object 1) and a novel object
(object 2) for 5 min (test phase). Both the trial and test phase
were recorded and the amount of time exploring objects was as-
sessed from the video recordings by two independent re-
searchers. The discrimination index (DI) was calculated as the
ratio of the amount of time animals spent with the novel versus
the familiar object. A positive value indicates that the animal
preferred to explore the novel object.
Y-maze test
Pups were allowed to habituate to the room for 30 min and then
placed at the end of the long arm of the maze. Animals were al-
lowed to move through the maze for 8 min. The test was re-
corded and the series of arm entries were recorded. An
alternation is considered as successive entries into the three
arms. The number of alternations was recorded and calculated
as a percentage of the total arm entries.
Brain sections and immunohistochemistry
During embryo sacrifice, whole heads were collected and fixed
in 4% PFA overnight. They were then paraffin embedded and
cut along the coronal axis at 5-lm thickness; mounted sections
were 10 sections apart. For the pups, the brain was cut along the
sagittal axis and the right hemisphere of the brain was fixed in
4% PFA. Sections were cut at 5-lm thickness. Hematoxylin and
eosin (H&E) staining was performed to assess brain morphol-
ogy. Slides were scanned using the Zeiss Axio Scan.Z1
(Oberkochen, Germany). The examined sections were chosen to
be at the same or similar levels between mice. Measurements of
area and thickness in the hippocampus were performed using
the Zen Lite 2 (Blue Edition) (Zeiss Microscopy, Oberkochen,
Germany) by two investigators blinded to groups. The hippo-
campal area value is an average of four sections per mouse. The
thickness values for dentate gyrus are the average of three mea-
surements per section, for four sections per mouse. Cholinergic
staining was done as previously described (44) using a ChAT
polyclonal goat antibody (Millipore, Billerica, USA). Positive cho-
linergic neurons were counted in 3–4 sections per animal (5 ani-
mals per group) in the Substantia Innominata (SI) at a
magnification of 400. Intensity of staining was measured using
ImageJ software.
Choline metabolites
Choline, betaine, acetylcholine (Ach), glycerophosphocholine
(GPC), phosphatidylcholine (PtdCho), sphingomyelin (SM), lyso-
phosphatidylcholine (LPC) and phosphocholine (PCho) were iso-
lated from frozen liver, brain, plasma and placenta using liquid–
liquid extraction and SPE purification (45). Stable isotope-
dilution liquid chromatography–electrospray ionization tandem
mass spectrometry was used for metabolite quantification
as previously described (45) with adaptations based on our in-
strumentation (46). Calibration curves for each metabolite were
prepared via serial dilutions of a 100 mM standard stock solu-
tion. Ranges were linear between 1 and 100 nmol/extract for
choline, betaine, PCho and GPC; 1–100 pmol/extract for Ach;
150–2500 nmol/extract for PtdCho; 6-100 nmol/extract for SM;
and 3–50 nmol/extract LPC. Stable isotope-dilution liquid
chromatography–electrospray ionization tandem mass spec-
trometry was also used to measure SAM and SAH concentra-
tions in placenta, liver and brain as previously described (47,48).
Calibration curves for SAM and SAH were prepared via serial
dilutions of 100 mM stock solutions and ranges were linear be-
tween 0.2 and 7.5 nmol/extract for SAM and 0.04–1.2 nmol/ex-
tract for SAH. Quality control for all metabolites was monitored
using duplicate samples of in-house control materials (i.e. ho-
mogenized pooled liver, brain and human placental tissues).
The assay imprecision (coefficient of variation) was<5% for be-
taine;<10% for free choline, SAM, SAH, GPC, PCho, PtdCho, SM,
LPC; and <16% for Ach.
Folates
Quantification of the major folates (folic acid, dihydrofolate, tet-
rahydrofolate (THF), methenylTHF, methyleneTHF, methylTHF
and formylTHF) in mono- and polyglutamated (1–7 glutamates)
forms was determined in hippocampus samples by liquid
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chromatography–electrospray ionization tandem mass spec-
trometry, as previously described (49). The relative abundance
of individual folate forms as a proportion of total folate was
compared between groups.
Quantitative real-time PCR
RNA was extracted from frozen liver (15 mg) using the RNeasy
Mini Kit (Qiagen, Toronto, Canada). RNA from brain was
extracted using the AllPrep DNA, RNA and miRNA Universal kit
(Qiagen, Toronto, Canada). cDNA synthesis was done using
the iScript cDNA Synthesis kit (BioRad, Quebec, Canada) and
quantitative real-time PCR reactions were done using the
SSoAdvanced Universal SYBR Green Supermix. For all tissues,
the following reference genes were tested: glyceraldehyde-3-
phosphate dehydrogenase (Gapdh), b-2-microglobulin (B2m), b –
actin (Actb) and tyrosine 3-monooxygenase/tryptophan 5-moox-
ygenase activation protein, zeta polypeptide (Ywhaz). The nor-
malization factor was calculated for each tissue using the two
most stably expressed genes by geNorm v.3.4 (Ghent University
Hospital Center for Medical Genetics) (50). Primers were
designed using the Primer-BLAST (National Center for
Biotechnology Information) (51). A complete list of primer se-
quences and reactions conditions is included in Supplementary
Material, Table S6.
Western blotting
Protein extracts were prepared as before (20) and the concentra-
tion was determined by Bradford Assay with a bovine serum al-
bumin standard. Western blots were performed as previously
described (20). Primary antibodies were against MTHFR (2),
ChAT (Millipore, Billerica, USA), GAPDH (Cell Signaling
Technology, Boston, USA) and b-actin (Sigma-Aldrich).
Secondary antibodies were horseradish peroxidase (HRP)-conju-
gated donkey anti-rabbit IgG (GE Healthcare, Mississauga,
Canada) and HRP-conjugated donkey anti-goat IgG (Santa Cruz
Biotechnology, Santa Cruz, USA), as appropriate. Detection was
achieved using ECL Prime Western Blotting Detection Reagent
(GE Healthcare, Mississauga, Canada). Bands were quantified by
densitometry using Quantity One 4.1.0 (Bio-Rad) and normal-
ized to loading control (GAPDH or b-actin).
Statistical analysis
Statistical analysis was performed with Graph Pad software
package 5.01 (GraphPad Software, La Jolla, USA, 1995). All data
are presented as mean6 standard error of the mean (SEM).
Statistical outliers, determined by using Grubb’s test (GraphPad
Software), were removed from the analysis. Data were analyzed
using an unpaired t-test. If the variance was statistically signifi-
cant, Welsh’s correction was applied. Results were considered
statistically significant at P 0.05.
Supplementary Material
Supplementary Material is available at HMG online.
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